J. Bishop

Dose intensity and outcome with combination chemotherapy for germ cell carcinoma. Australasian Germ Cell Trial Group.

M. Tattersall, V. Harvey, D. Raghavan, 1989, European journal of cancer & clinical oncology.

Phase II trial of carboplatin in the management of malignant mesothelioma.

P. Bye, B. McCaughan, D. Raghavan, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy in metastatic melanoma: phase II studies of amsacrine, mitoxantrone and bisantrene.

G. Mann, A. Coates, D. Raghavan, 1986, European Journal of Cancer and Clinical Oncology.

A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tract.

R. Kefford, D. Raghavan, I. Olver, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Carboplatin-containing regimens for small cell lung cancer: implications for management in the elderly.

J. Zalcberg, R. Kefford, J. Matthews, 1992, Seminars in oncology.

1084 Interim results of a phase II trial of docetaxel in combination with cisplatin in patients with metastatic or locally advanced non-small cell lung cancer (NSCLC)

J. Zalcberg, M. Millward, M. Friedlander, 1995 .

The cost of breast cancer recurrences.

S. Hurley, R. Snyder, S. F. Hurley, 1992, British Journal of Cancer.